Metabolic Syndrome Is Associated with Impaired Survival after Surgery for Pancreatic Neuroendocrine Tumors.

Fayez Awwad, Ann-Kathrin Ozga,Tania Amin,Catarina Schlueter,Sajeda Kailani,Daniel Perez,Stefan Wolter,Guido Sauter,Jakob Izbicki,Ansgar Wilhelm Lohse,Joerg Schrader

Neuroendocrinology（2022）

引用 2|浏览2

暂无评分

摘要

We identified MetS as a negative prognostic factor after curative intended surgery for pNET. In particular, patients with oligometastatic disease might not benefit from extensive surgery in the presence of MetS. Furthermore, MetS had a strong impact on survival after recurrence.

查看译文

关键词

Body mass index,Diabetes,Metabolic syndrome,Pancreatic neuroendocrine tumors,Statin

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要